Pyogenic liver abscess in non‐liver cancer patients and liver cancer patients treated with TACE: Etiological characteristics, treatment, and outcome analysis
Abstract Clinical, laboratory, and microbiological features, clinical outcomes, and pyogenic liver abscess (PLA) prognosis evaluation in non‐liver cancer (Non‐LC) and liver cancer patients treated with transarterial chemoembolization (TACE, LC‐TACE). Clinical data of 48 consecutive PLA patients from...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Kaohsiung Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/kjm2.12613 |
| _version_ | 1797955817830350848 |
|---|---|
| author | Yi‐Ming Liu Yan‐Qiao Ren Song‐Lin Song Chuan‐Sheng Zheng |
| author_facet | Yi‐Ming Liu Yan‐Qiao Ren Song‐Lin Song Chuan‐Sheng Zheng |
| author_sort | Yi‐Ming Liu |
| collection | DOAJ |
| description | Abstract Clinical, laboratory, and microbiological features, clinical outcomes, and pyogenic liver abscess (PLA) prognosis evaluation in non‐liver cancer (Non‐LC) and liver cancer patients treated with transarterial chemoembolization (TACE, LC‐TACE). Clinical data of 48 consecutive PLA patients from January 2016 to December 2020 were retrospectively analyzed. Mortality between two PLA patient groups were compared, and mortality risk factors were evaluated. A total of 48 PLA patients (31 males and 17 females) from January 2016 to December 2020 met the study's inclusion criteria. There were 32 and 16 patients in the Non‐LC and LC‐TACE groups, respectively. Positive pus culture rate in the Non‐LC group was 87.5% and positive pus culture rate in LC‐TACE group was 81.3%. In the Non‐LC group, 28 patients improved after treatment, 1 patient did not improve, and 3 patients died during hospitalization, with a 9.4% mortality rate. In the LC‐TACE group, nine patients improved after treatment, three patients did not improve, and four patients died during hospitalization, with a 25% mortality rate. The Non‐LC group cure time was 37.4 ± 23.1 days, while the LC‐TACE group was 91.5 ± 49.7 days. PLA of the Non‐LC group and the LC‐TACE group were different in terms of pathogenic bacteria and cure time, and so on. A more comprehensive treatment should be considered for PLA after TACE. |
| first_indexed | 2024-04-10T23:39:04Z |
| format | Article |
| id | doaj.art-2bc57a750d4f44719e351e39472bbdb7 |
| institution | Directory Open Access Journal |
| issn | 1607-551X 2410-8650 |
| language | English |
| last_indexed | 2024-04-10T23:39:04Z |
| publishDate | 2023-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Kaohsiung Journal of Medical Sciences |
| spelling | doaj.art-2bc57a750d4f44719e351e39472bbdb72023-01-11T10:47:14ZengWileyKaohsiung Journal of Medical Sciences1607-551X2410-86502023-01-01391879410.1002/kjm2.12613Pyogenic liver abscess in non‐liver cancer patients and liver cancer patients treated with TACE: Etiological characteristics, treatment, and outcome analysisYi‐Ming Liu0Yan‐Qiao Ren1Song‐Lin Song2Chuan‐Sheng Zheng3Department of Radiology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan ChinaDepartment of Radiology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan ChinaDepartment of Radiology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan ChinaDepartment of Radiology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan ChinaAbstract Clinical, laboratory, and microbiological features, clinical outcomes, and pyogenic liver abscess (PLA) prognosis evaluation in non‐liver cancer (Non‐LC) and liver cancer patients treated with transarterial chemoembolization (TACE, LC‐TACE). Clinical data of 48 consecutive PLA patients from January 2016 to December 2020 were retrospectively analyzed. Mortality between two PLA patient groups were compared, and mortality risk factors were evaluated. A total of 48 PLA patients (31 males and 17 females) from January 2016 to December 2020 met the study's inclusion criteria. There were 32 and 16 patients in the Non‐LC and LC‐TACE groups, respectively. Positive pus culture rate in the Non‐LC group was 87.5% and positive pus culture rate in LC‐TACE group was 81.3%. In the Non‐LC group, 28 patients improved after treatment, 1 patient did not improve, and 3 patients died during hospitalization, with a 9.4% mortality rate. In the LC‐TACE group, nine patients improved after treatment, three patients did not improve, and four patients died during hospitalization, with a 25% mortality rate. The Non‐LC group cure time was 37.4 ± 23.1 days, while the LC‐TACE group was 91.5 ± 49.7 days. PLA of the Non‐LC group and the LC‐TACE group were different in terms of pathogenic bacteria and cure time, and so on. A more comprehensive treatment should be considered for PLA after TACE.https://doi.org/10.1002/kjm2.12613liver cancerpathogenic bacteriapyogenic liver abscesstransarterial chemoembolization |
| spellingShingle | Yi‐Ming Liu Yan‐Qiao Ren Song‐Lin Song Chuan‐Sheng Zheng Pyogenic liver abscess in non‐liver cancer patients and liver cancer patients treated with TACE: Etiological characteristics, treatment, and outcome analysis Kaohsiung Journal of Medical Sciences liver cancer pathogenic bacteria pyogenic liver abscess transarterial chemoembolization |
| title | Pyogenic liver abscess in non‐liver cancer patients and liver cancer patients treated with TACE: Etiological characteristics, treatment, and outcome analysis |
| title_full | Pyogenic liver abscess in non‐liver cancer patients and liver cancer patients treated with TACE: Etiological characteristics, treatment, and outcome analysis |
| title_fullStr | Pyogenic liver abscess in non‐liver cancer patients and liver cancer patients treated with TACE: Etiological characteristics, treatment, and outcome analysis |
| title_full_unstemmed | Pyogenic liver abscess in non‐liver cancer patients and liver cancer patients treated with TACE: Etiological characteristics, treatment, and outcome analysis |
| title_short | Pyogenic liver abscess in non‐liver cancer patients and liver cancer patients treated with TACE: Etiological characteristics, treatment, and outcome analysis |
| title_sort | pyogenic liver abscess in non liver cancer patients and liver cancer patients treated with tace etiological characteristics treatment and outcome analysis |
| topic | liver cancer pathogenic bacteria pyogenic liver abscess transarterial chemoembolization |
| url | https://doi.org/10.1002/kjm2.12613 |
| work_keys_str_mv | AT yimingliu pyogenicliverabscessinnonlivercancerpatientsandlivercancerpatientstreatedwithtaceetiologicalcharacteristicstreatmentandoutcomeanalysis AT yanqiaoren pyogenicliverabscessinnonlivercancerpatientsandlivercancerpatientstreatedwithtaceetiologicalcharacteristicstreatmentandoutcomeanalysis AT songlinsong pyogenicliverabscessinnonlivercancerpatientsandlivercancerpatientstreatedwithtaceetiologicalcharacteristicstreatmentandoutcomeanalysis AT chuanshengzheng pyogenicliverabscessinnonlivercancerpatientsandlivercancerpatientstreatedwithtaceetiologicalcharacteristicstreatmentandoutcomeanalysis |